Nilotinib Powder
- Product Name:4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester
- CAS No.：917392-54-2
- MF: C18H16N4O2
- Ensayo: 99%
- Appearance: Pale-yellow solid
- Molecular Weight: 320.35
- Nuestro embalaje: 25 kg/barril, 10 kg/25 kg/caja, 1 kg/5 kg/10 kg/bolsa o su solicitud
Detalles del producto
Nilotinib powder is a second-generation, next-generation targeted drug developed and sold by Novartis in Switzerland for the treatment of chronic myeloid leukemia. Raw powder antiacncer nilotinib powder, methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate is a key intermediate of the chemotherapeutic drug nilotinib. The drug is safe and effective in the treatment of chronic myeloid leukemia/chronic myeloid leukemia patients taking imatinib for drug resistance. It is a tyrosine kinase inhibitor, and its content mainly inhibits BCR-ABL, KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11, ZAK kinases, etc. Dashina (nilotinib) is a new type of targeted tumor therapy drug, which has a significant effect on chronic myeloid leukemia (CML) patients who are resistant or intolerant to Gleevec (imatinib).
Beneficios para la salud
Nilotinib is a first-line oral targeted therapy for the treatment of chronic myeloid leukemia/chronic myeloid leukemia (CML).
- Treatment of newly diagnosed Philadelphia chromosome positive (Ph+) adult chronic myeloid leukemia in the chronic phase.
- Treatment of Philadelphia chromosome-positive chronic myeloid leukemia in blast phase and accelerated phase.
- Treatment of chronic myeloid leukemia in the chronic phase that has been treated with interferon Chemicalbook.
- Children with chronic myeloid leukemia who have relapsed after myelosuppression or who are ineffective in interferon therapy.
- Treatment of KIT(CD117)-positive inoperable or metastatic malignant gastrointestinal stromal tumors.
* Esta declaración es solo para fines educativos. No ha sido evaluada por la Administración de Alimentos y Medicamentos (FDA). Este producto no está destinado a diagnosticar, tratar, curar ni prevenir ninguna enfermedad.
